Multiple passage of VSV-IFNβ through human Hep3B-CSDE1WT (as a model of human hepatocellular cancer cells against which we are testing VSV-IFNβ in clinical trials) increased replication compared to passage through Hep3BP parental cells (Fig. 1F). The gene discussed is IFNB1; the disease is hepatocellular carcinoma.